跳至主要内容
临床试验/NCT05674292
NCT05674292已完成不适用

An Evaluation of the Effect of the Erchonia Corporation Violet Zerona® Z6 for Body Contouring

Erchonia Corporation4 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2022年7月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25
试验地点
4
主要终点
Combined Circumference Reduction in Inches of the Waist, Hips, and Bilateral Thighs

研究概览

简要总结

The purpose of this clinical study is to determine the effectiveness of the Erchonia® Violet Zerona Z6 (manufactured by Erchonia Corporation (the Company), an over-the-counter (OTC) laser device, in providing noninvasive body circumference reduction.

详细描述

The clinical study is an open-label non-inferiority design to evaluate the efficacy of the Erchonia® Violet Zerona Z6, an over-the-counter (OTC) laser device, in providing noninvasive circumference reduction. The clinical study protocol is based on the protocol for the clinical study whose results were submitted in support of clearance of the predicate device, the Erchonia® Zerona® Z6 OTC.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI is 30 or less
  • 18 years of age or older

排除标准

  • Open wounds (sores, cuts, ulcers, etc.)
  • Individuals with or being treated for any cancerous growth

结局指标

主要结局

Combined Circumference Reduction in Inches of the Waist, Hips, and Bilateral Thighs

时间窗: 2 weeks

Mean change in total combined circumference inches of the waist, hips and bilateral thighs from baseline to endpoint evaluation.

次要结局

未报告次要终点

研究者

发起方
Erchonia Corporation
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验